Mucinex and Alkeran drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mucinex (guaifenesin) and Alkeran (melphalan). Common drug interactions include cardiomegaly among females and abscess jaw among males.

The phase IV clinical study analyzes what interactions people have when they take Mucinex and Alkeran. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Mucinex?

Mucinex has active ingredients of guaifenesin. It is often used in cough. eHealthMe is studying from 29,749 Mucinex users. Check the latest studies of Mucinex.

What is Alkeran?

Alkeran has active ingredients of melphalan. eHealthMe is studying from 5,429 Alkeran users. Check the latest studies of Alkeran.



On Aug, 02, 2026

15 people who take Mucinex and Alkeran together, and have interactions are studied.

Mucinex and Alkeran drug interactions.

What are the common drug interactions of Mucinex and Alkeran, by gender? *:

female:

  1. Cardiomegaly (increased size of heart than normal)
  2. Chills (felling of cold)
  3. Colitis (inflammation of colon)
  4. Constipation
  5. Diarrhoea
  6. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  7. Emotional distress
  8. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  9. Empyema (collection of pus in a cavity in the body)
  10. Exostosis (formation of new bone on the surface of a bone)

male:

  1. Abscess jaw (tooth abscess or root abscess)
  2. Anaemia of chronic disease
  3. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  4. Brain injury
  5. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  8. Cardiac failure congestive
  9. Cardiomegaly (increased size of heart than normal)
  10. Cataract (clouding of the lens inside the eye)

What are the common drug interactions of Mucinex and Alkeran, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anaemia of chronic disease
  2. Anxiety
  3. Arteriosclerosis (thickening and hardening of arteries)
  4. Arthralgia (joint pain)
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  6. Arthropathy
  7. Asthenia (weakness)
  8. Atelectasis (partial or complete collapse of the lung)
  9. Back pain
  10. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)

30-39:

n/a

40-49:

n/a

50-59:

  1. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Fluid retention (an abnormal accumulation of fluid in the blood)
  4. Gallbladder disorder
  5. Hip fracture
  6. Hypertension (high blood pressure)
  7. Osteoporosis (bones weak and more likely to break)
  8. Weight decreased
  9. Wound infection staphylococcal

60+:

  1. Anxiety
  2. Back pain
  3. Emotional distress
  4. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  5. Empyema (collection of pus in a cavity in the body)
  6. Exostosis (formation of new bone on the surface of a bone)
  7. Fatigue (feeling of tiredness)
  8. Granuloma (a small area of inflammation due to tissue injury)
  9. Haematochezia (passage of stools containing blood)
  10. Haemorrhoids (a swollen vein or group of veins in the region of the anus)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 1 person, 6.67%
  2. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 6.67%
  3. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 6.67%
  4. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 6.67%
  5. Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 1 person, 6.67%
  6. Acne (skin problems that cause pimples): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Mucinex and Alkeran?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mucinex and Alkeran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mucinex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Alkeran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mucinex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Alkeran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on guaifenesin and melphalan (the active ingredients of Mucinex and Alkeran, respectively), and Mucinex and Alkeran (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: